CIK 0001720580 · Non-accelerated filer<br>Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813305277
- Phone
- 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +74,751 | $7.27 | $543K | 1,182,624 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +74,268 | $7.21 | $535K | 1,107,873 |
| 2026-02-18 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +74,577 | $7.04 | $525K | 1,033,605 |
| 2026-01-24 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −535 | $8.44 | $5K | 2,981 |
| 2026-01-24 | Healey Don Chief Technology Officer | Shares withheld for taxes | −535 | $8.44 | $5K | 3,452 |
| 2026-01-24 | Schor Chen President & CEO | Shares withheld for taxes | −1,755 | $8.44 | $15K | 6,820 |
| 2026-01-24 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −546 | $8.44 | $5K | 5,145 |
| 2025-10-08 | ORBIMED ADVISORS LLC 10% owner | Purchase | +1,500,000 | $1.00 | $1.5M | 9,026,359 |
| 2025-10-08 | ORBIMED ADVISORS LLC 10% owner | Purchase | +3,500,000 | $1.00 | $3.5M | 4,490,254 |
| 2025-06-11 | Klickstein Lloyd Director | Grant or award | +5,900 | 108,566 | ||
| 2025-06-11 | Klickstein Lloyd Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2025-06-11 | Chodakewitz Jeffrey Director | Grant or award | +5,900 | 17,700 | ||
| 2025-06-11 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2025-06-11 | DUBIN STEVE Director | Grant or award | +5,900 | 22,700 | ||
| 2025-06-11 | DUBIN STEVE Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2025-06-11 | Peng Katie Director | Grant or award | +5,900 | 11,800 | ||
| 2025-06-11 | Peng Katie Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2025-06-11 | Sinclair Andrew Director | Grant or award | +5,900 | 17,700 | ||
| 2025-06-11 | Sinclair Andrew Director | Grant or award · Stock Option (Right to Buy) | +26,400 | 26,400 | ||
| 2025-04-17 | Grissinger Michael Director | Grant or award · Stock Option (Right to Buy) | +70,200 | 70,200 |
Page 2 of 15 · 298 trades